Kushida, Clete A. https://orcid.org/0000-0002-9430-3752
Stevens, James
Bennett, Michael
Heit, Tammarie
Klemp, Dennis
Raio, Dean
Cozean, Jesse
Cozean, Colette
Article History
Received: 13 April 2025
Revised: 30 May 2025
Accepted: 3 June 2025
First Online: 17 June 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The protocol was approved by the WCG Institutional Review Board.
: Written informed consent was obtained from all legally authorized representatives of the individual participants included in the study.
: Not applicable.
: The clinical sites received no funding from the sponsor (Vivos Therapeutics, Inc.). Author Dr. Clete Kushida receives fees and stock options for his role as chair of the sponsor’s medical advisory board. Author Dr. Michael Bennett receives fees from the sponsor for his mentorship of dentists who receive sponsor training in the oral appliance treatment. Author Dr. Tammarie Heit receives honoraria and travel expenses from the sponsor for educational activities. Authors Jesse Cozean and Dr. Colette Cozean were paid by The EyeDeas Company, which served as the regulatory consultant for the sponsor for its services in IRB/clinicaltrials.gov communication, site training, collecting/preliminarily analyzing data, and writing of the manuscript.